Erratum: Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review (European Journal of Clinical Nutrition, (2014), 68, 4, (510-516), 10.1038/ejcn.2014.7);Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review

European Journal of Clinical Nutrition

Volumn 68, Issue 4, 2014, Pages 510-516

  Dibaba, D T ^a   Xun, P ^a   He, K ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

C reactive protein; Inflammation; Magnesium; Meta analysis; Systematic review

Indexed keywords

C REACTIVE PROTEIN; MAGNESIUM;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; EXPERIMENTAL STUDY; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAGNESIUM BLOOD LEVEL; META ANALYSIS; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SMOKING; SYSTEMATIC REVIEW; BLOOD; DIET; METABOLISM;

C-REACTIVE PROTEIN; DIET; HUMANS; MAGNESIUM; OBSERVATIONAL STUDY AS TOPIC;

EID: 84897976538     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.273     Document Type: Erratum

References (37)

1. Liu S, Chacko S. Dietary Mg intake and biomarkers of inflammation and endothelial dysfunction. In: Watson RR, Preedy VR, Zibadi S eds. Magnesium in Human Health and Disease. Humana Press: New York, 2013, pp 35-50.
2. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006; 113: 1675-1682.
3. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Resi 2006; 19: 237-243.
4. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-Aged and older U.S. women. Diabetes Care 2005; 28: 1438-1444.
5. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 59-65.
6. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003; 92: 665-669.
7. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 2004; 23: 63-70.
8. Stevanovic S, Nikolic M, Stankovic A. Dietary magnesium intake and coronary heart disease risk: A study from Serbia. Med Glas 2011; 8: 203-208.
9. Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010; 68: 333-340.
10. King DE, Mainous 3rd AG, Geesey ME, Ellis T. Magnesium intake and serum C-reactive protein levels in children. Magnes Res 2007; 20: 32-36.
11. Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002; 26: 469-474.
12. King DE, Mainous AG, Geesey ME, Egan BM, Rehman S. Magnesium supplement intake and C-reactive protein levels in adults. Nutr Res 2006; 26: 193-196.
13. Chacko SA, Song Y, Nathan L, Tinker L, De Boer IH, Tylavsky F et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33: 304-310.
14. De Oliveira Otto MC, Alonso A, Lee DH, Delclos GL, Jenny NS, Jiang R et al. Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis. J Nutr 2011; 141: 1508-1515.
15. Song Y, Li TY, Van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85: 1068-1074.
16. Higgins RMHaJPT. STATA Journal 2008; 8 (Number 4): 493-519.
17. Bo S, Durazzo M, Guidi S, Carello M, Sacerdote C, Silli B et al. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-Aged subjects from a population-based cohort. Am J Clin Nutr 2006; 84: 1062-1069.
18. King DE, Mainous 3rd AG, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 2005; 24: 166-171.
19. Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-Analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011; 11: 41.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-Analysis. Stat Med 2002; 21: 1539-1558.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-Analysis detected by a simple, graphical test. Bmj 1997; 315: 629-634.
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
23. Rodriguez-Moran M, Guerrero-Romero F. Serum magnesium and C-reactive protein levels. Archives of disease in childhood 2008; 93: 676-680.
24. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs Jr DR et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010; 33: 2604-2610.
25. Almoznino-Sarafian D, Berman S, Mor A, Shteinshnaider M, Gorelik O, Tzur I et al. Magnesium and C-reactive protein in heart failure: An anti-inflammatory effect of magnesium administration? Eur J Nutr 2007; 46: 230-237.
26. Nielsen FH, Johnson LK, Zeng H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res 2010; 23: 158-168.
27. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y et al. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: A randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011; 93: 463-473.
28. Wong ET, Rude RK, Singer FR, Shaw Jr ST. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983; 79: 348-352.
29. McLaughlin SA, McKinney PE. Antacid-induced hypermagnesemia in a patient with normal renal function and bowel obstruction. Ann Pharmacother 1998; 32: 312-315.
30. Uchiyama C, Kato T, Tomida K, Suzuki R, Nakata K, Hamanaka M et al. Fatal hypermagnesemia induced by preoperative colon preparation in an elderly woman: Report of a case. Clin J Gastroenterol 2013; 6: 105.
31. World Health Organization. Calcium and Magnesium in Drinking-water: Public Health Significance. Geneva, Switzerland: World Health Organization, 2009, xi, 180 pp
32. Moslehi N, Vafa M, Rahimi-Foroushani A, Golestan B. Effects of oral magnesium supplementation on inflammatory markers in middle-Aged overweight women. J Res Med Sci 17: 607-613.
33. Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero- Romero F. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Magnes Res 2010; 23: 90-96.
34. Svagzdiene M, Rupsa T, Sirvinskas E, Baranauskiene D, Abdrachmanovas O. P-74 Relation of magnesium level in serum, erythrocytes, and cardiac tissue and C-reactive protein. J Cardiothorac Vasc Anesth 2011; 25: S64.
35. Bussiere FI, Tridon A, Zimowska W, Mazur A, Rayssiguier Y. Increase in complement component C3 is an early response to experimental magnesium deficiency in rats. Life Sci 2003; 73: 499-507.
36. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56.
37. Dong A, Caughey WS, Du Clos TW. Effects of calcium, magnesium, and phosphorylcholine on secondary structures of human C-reactive protein and serum amyloid P component observed by infrared spectroscopy. J Biol Chem 1994; 269: 6424-6430.